REFERENCES
- Gibbs R A, Chamberlain J S, Caskey C T. Diagnostic of new mutation diseases using the polymerase chain reaction. PCR Technology, Principles and applications for DNA amplification, H A Erlich. Macmillan, Hants 1989; 171–193
- Al-Soud W A, Radstrom P. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol 2001; 39: 485–493, [INFOTRIEVE], [CSA]
- Födinger M, Walter H H, Sunder-Plassman G. Molecular biology of 5,10-methylentetrahydrofolate reductase. J Nephrol 2000; 13: 20–33, [CSA]
- Frosst P, Blom H J, Milos R, et al. A candidate gene risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase. Nat Genet. 1995; 10: 111–113, [INFOTRIEVE], [CSA], [CROSSREF]
- Beutler E, Gelbert T, Kuhl W. Interference of heparin with the polymerase chain reaction. Biotechniques. 1990; 9: 166, [INFOTRIEVE], [CSA]
- Yokota M, Tatsumi N, Nathalang O, Yamada T, Tsuda I. Effects of heparin on polymerase chain reaction for blood white cells. J Clin Lab Anal 1999; 13: 133–140, [INFOTRIEVE], [CSA], [CROSSREF]